Business News

Ironwood Inks $1 Billion Deal to Acquire VectivBio

May 24, 2023

Ironwood Pharmaceuticals’ acquisition of VectivBio grants it the rights to apraglutide, a glucagon-like peptide being evaluated for gastrointestinal diseases.

Astellas and Sony Enter ADC Platform Collaboration

May 17, 2023

Astellas and Sony will collaborate to discover a novel ADC platform for use in oncology.

FTC Sues to Block Amgen’s $27.8 Billion Acquisition of Horizon Therapeutics

May 16, 2023

In a brief, the Federal Trade Commission cited concerns about the acquisition resulting in an increased monopoly on Amgen’s newly acquired thyroid eye disease and chronic refractory gout treatments.

Bright Path Laboratories to Collaborate in NSF Engines Development Program

May 16, 2023

The NSF-sponsored program aims to help partners collaborate to create opportunities for significant economic, societal, and technological opportunities for growth in their regions.

Amgen and Tscan Therapeutics Team Up to Identify Novel Targets in Crohn's Disease

May 12, 2023

In a deal potentially worth more than $530 million, Amgen will use TScan Therapeutics’ target discovery platform to home in on novel targets for Crohn’s disease treatment.

Sandoz and Just – Evotec Biologics Form Biosimilars Pact

May 12, 2023

The new partnership between Sandoz, a Novartis division, and Just – Evotec Biologics will aim to develop and manufacture multiple biosimilars.

Baxter Divests BioPharma Solutions Department in $4.25 Billion Deal

May 10, 2023

Private investors from Advent International and Warburg Pincus will operate the assets as an independent CDMO.

Ginkgo Bioworks and Boehringer Ingelheim Sign $405 Million Drug Discovery Deal

May 09, 2023

Boehringer Ingelheim will use Ginkgo’s metagenomic sequence database to identify potential lead molecules for diseases with high unmet patient needs.

Aspect Biosystems, Novo Nordisk Partner to Develop Bioprinted Tissue Therapeutics

April 25, 2023

Aspect Biosystems and Novo Nordisk A/S have announced a collaboration, development, and license agreement to develop bioprinted tissue therapeutics.